<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis - Shea, B - 2013 | Cochrane Library</title> <meta content="Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis - Shea, B - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000951.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis - Shea, B - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000951.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD000951.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis" name="citation_title"/> <meta content="Beverley Shea" name="citation_author"/> <meta content="University of Ottawa" name="citation_author_institution"/> <meta content="bevshea@uottawa.ca" name="citation_author_email"/> <meta content="Michael V Swinden" name="citation_author"/> <meta content="University of Ottawa" name="citation_author_institution"/> <meta content="Elizabeth Tanjong Ghogomu" name="citation_author"/> <meta content="University of Ottawa" name="citation_author_institution"/> <meta content="Zulma Ortiz" name="citation_author"/> <meta content="National Academy of Medicine" name="citation_author_institution"/> <meta content="Wanruchada Katchamart" name="citation_author"/> <meta content="Siriraj Hospital, Mahidol University" name="citation_author_institution"/> <meta content="Tamara Rader" name="citation_author"/> <meta content="Cochrane Musculoskeletal Group" name="citation_author_institution"/> <meta content="Claire Bombardier" name="citation_author"/> <meta content="Institute for Work &amp; Health" name="citation_author_institution"/> <meta content="George A Wells" name="citation_author"/> <meta content="University of Ottawa" name="citation_author_institution"/> <meta content="Peter Tugwell" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD000951.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/05/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000951.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000951.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000951.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Abdominal Pain [chemically induced, prevention &amp; control]; Antirheumatic Agents [*adverse effects, therapeutic use]; Arthritis, Rheumatoid [*drug therapy]; Folic Acid [administration &amp; dosage, *therapeutic use]; Folic Acid Antagonists [*adverse effects, therapeutic use]; Gastrointestinal Diseases [chemically induced, prevention &amp; control]; Hematologic Diseases [chemically induced, prevention &amp; control]; Leucovorin [administration &amp; dosage, *therapeutic use]; Methotrexate [*adverse effects, therapeutic use]; Nausea [chemically induced, prevention &amp; control]; Vomiting [chemically induced, prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD000951.pub2&amp;doi=10.1002/14651858.CD000951.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="eLIOL3Be";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD000951\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD000951\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","ru","pt","ko","ms","ja","hr","fr","zh_HANT","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD000951.pub2",title:"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis",firstPublishedDate:"May 31, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Musculoskeletal Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=eLIOL3Be&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000951.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000951.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD000951.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD000951.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000951.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD000951.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD000951.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD000951.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD000951.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD000951.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>25407 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD000951.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-abs-0008"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-sec-0100"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-sec-0050"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-sec-0051"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-sec-0056"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-sec-0057"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-sec-0079"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-sec-0095"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/appendices#CD000951-sec-0105"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/table_n/CD000951StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/table_n/CD000951StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information#CD000951-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Beverley Shea</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information#CD000951-cr-0003">Michael V Swinden</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information#CD000951-cr-0004">Elizabeth Tanjong Ghogomu</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information#CD000951-cr-0005">Zulma Ortiz</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information#CD000951-cr-0006">Wanruchada Katchamart</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information#CD000951-cr-0007">Tamara Rader</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information#CD000951-cr-0008">Claire Bombardier</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information#CD000951-cr-0009">George A Wells</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information#CD000951-cr-0010">Peter Tugwell</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information/en#CD000951-sec-0117">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 May 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD000951.pub2">https://doi.org/10.1002/14651858.CD000951.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD000951-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000951-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD000951-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000951-abs-0020">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000951-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD000951-abs-0005">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD000951-abs-0004">한국어</a> </li> <li class="section-language"> <a class="" href="full/pt#CD000951-abs-0003">Português</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000951-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD000951-abs-0001" lang="en"> <section id="CD000951-sec-0001"> <h3 class="title" id="CD000951-sec-0001">Background</h3> <p>Methotrexate (MTX) is a disease modifying antirheumatic drug (DMARD) used as a first line agent for treating rheumatoid arthritis (RA). Pharmacologically, it is classified as an antimetabolite due to its antagonistic effect on folic acid metabolism. Many patients treated with MTX experience mucosal, gastrointestinal, hepatic or haematologic side effects. Supplementation with folic or folinic acid during treatment with MTX may ameliorate these side effects. </p> </section> <section id="CD000951-sec-0002"> <h3 class="title" id="CD000951-sec-0002">Objectives</h3> <p>To identify trials of supplementation with folic acid or folinic acid during MTX therapy for rheumatoid arthritis and to assess the benefits and harms of folic acid and folinic acid (a) in reducing the mucosal, gastrointestinal (GI), hepatic and haematologic side effects of MTX, and (b) whether or not folic or folinic acid supplementation has any effect on MTX benefit. </p> </section> <section id="CD000951-sec-0003"> <h3 class="title" id="CD000951-sec-0003">Search methods</h3> <p>We originally performed MEDLINE searches, from January 1966 to June 1999. During the update of this review, we searched additional databases and used a sensitive search strategy designed to retrieve all trials on folic acid or folinic acid for rheumatoid arthritis from 1999 up to 2 March 2012. </p> </section> <section id="CD000951-sec-0004"> <h3 class="title" id="CD000951-sec-0004">Selection criteria</h3> <p>We selected all double‐blind, randomised, placebo‐controlled clinical trials (RCTs) in which adult patients with rheumatoid arthritis were treated with MTX (at a dose equal to or less than 25 mg/week) concurrently with folate supplementation. In this update of the review we only included trials using 'low dose' folic or folinic acid (a starting dose of ≤ 7 mg weekly). </p> </section> <section id="CD000951-sec-0005"> <h3 class="title" id="CD000951-sec-0005">Data collection and analysis</h3> <p>Data were extracted from the trials, and the trials were independently assessed for risk of bias using a predetermined set of criteria. </p> </section> <section id="CD000951-sec-0006"> <h3 class="title" id="CD000951-sec-0006">Main results</h3> <p>Six trials with 624 patients were eligible for inclusion. Most studies had low or unclear risk of bias for key domains. The quality of the evidence was rated as 'moderate' for each outcome as assessed by GRADE, with the exception of haematologic side effects which were rated as 'low'. There was no significant heterogeneity between trials, including where folic acid and folinic acid studies were pooled. </p> <p>For patients supplemented with any form of exogenous folate (either folic or folinic acid) whilst on MTX therapy for rheumatoid arthritis, a 26% relative (9% absolute) risk reduction was seen for the incidence of GI side effects such as nausea, vomiting or abdominal pain (RR 0.74, 95% CI 0.59 to 0.92; P = 0.008). Folic and folinic acid also appear to be protective against abnormal serum transaminase elevation caused by MTX, with a 76.9% relative (16% absolute) risk reduction (RR 0.23, 95% CI 0.15 to 0.34; P &lt; 0.00001), as well as reducing patient withdrawal from MTX for any reason (60.8% relative (15.2% absolute) risk reduction, RR 0.39, 95% CI 0.28 to 0.53; P &lt; 0.00001). </p> <p>We analysed the effect of folic or folinic acid on the incidence of stomatitis / mouth sores, and whilst showing a trend towards reduction in risk, the results were not statistically significant (RR 0.72, 95% CI 0.49 to 1.06) </p> <p>It was not possible to draw meaningful conclusions on the effect of folic or folinic acid on haematologic side effects of methotrexate due to small numbers of events and poor reporting of this outcome in included trials. </p> <p>It does not appear that supplementation with either folic or folinic acid has a statistically significant effect on the efficacy of MTX in treating RA (as measured by RA disease activity parameters such as tender and swollen joint counts, or physician's global assessment scores). </p> </section> <section id="CD000951-sec-0007"> <h3 class="title" id="CD000951-sec-0007">Authors' conclusions</h3> <p>The results support a protective effect of supplementation with either folic or folinic acid for patients with rheumatoid arthritis during treatment with MTX. </p> <p>There was a clincally important significant reduction shown in the incidence of GI side effects, hepatic dysfunction (asmeasured by elevated serum transaminase levels) as well as a clincally important significant reduction in discontinuation of MTX treatment for any reason. A trend towards a reduction in stomatitis was demonstrated however this did not reach statistical significance. </p> <p>This updated review with its focus on lower doses of folic acid and folinic acid and updated assessment of risk of bias aimed to give a more precise and more clinically relevant estimate of the benefit of folate supplementation for patients with rheumatoid arthritis receiving methotrexate. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD000951-abs-0008" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD000951-abs-0008">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD000951-abs-0010">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD000951-abs-0018">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD000951-abs-0021">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD000951-abs-0017">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD000951-abs-0016">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD000951-abs-0015">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD000951-abs-0013">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD000951-abs-0014">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD000951-abs-0012">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD000951-abs-0011">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD000951-abs-0009">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD000951-abs-0019">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD000951-abs-0008" lang="en"> <h3>Folic acid or folinic acid for reducing side effects of methotrexate for people with rheumatoid arthritis </h3> <p>Researchers in The Cochrane Collaboration conducted a review of the effect of folic acid or folinic acid for people taking methotrexate for rheumatoid arthritis. After searching for all relevant studies, six studies with up to 624 people were included in the review. Their findings are summarized below. </p> <p><b>In people with rheumatoid arthritis who take methotrexate (MTX):</b> </p> <p>‐ Taking either folic or folinic acid probably improves some side effects of MTX such as nausea and abdominal pain </p> <p>‐ Taking either folic or folinic acid probably reduces the chance of developing abnormal liver blood tests </p> <p>‐ Taking either folic or folinic acid probably helps people continue on their MTX treatment </p> <p>‐ Taking either folic or folinic acid may improve some side effects of MTX such as mouth sores </p> <p>‐ We are unable to ascertain whether or not taking folic or folinic acid with MTX prevents neutropenia (problems with producing white blood cells) </p> <p>‐ Taking folic or folinic acid with MTX probably has no effect on how well MTX is able to treat rheumatoid arthritis. </p> <p><b>What are folic acid and folinic acids and why do people take them with MTX?</b> </p> <p>Folic acid and folinic acid are forms of vitamin B9. The human body needs folate to perform many functions, including cell division, growth, and the production of new red blood cells. Folinic acid is chemically different to folic acid but both work in a similar way. If a person does not have enough folic acid or folinic acid, it is called a folate deficiency. MTX (a medication that is commonly prescribed to treat rheumatoid arthritis) works by blocking some of the effects of folic acid. A folate deficiency may cause side effects such as mouth sores, stomach problems such as nausea or abdominal pain, liver problems or problems with producing blood cells. These side effects are sometimes bad enough that they cause people to stop taking MTX (discontinue treatment). </p> <p><b>Best estimate of what happens to people who take folic acid or folinic acid while on MTX</b> </p> <p>Stomach problems such as nausea, vomiting or abdominal pain:</p> <p>‐ 9 fewer people out of 100 experienced stomach problems such as nausea up to 6 to 12 months after starting folic acid or folinic acid with their MTX (9.0% absolute improvement); </p> <p>‐ 35 people out of 100 experienced stomach problems such as nausea when they took MTX alone for their rheumatoid arthritis; </p> <p>‐ 26 people out of 100 experienced stomach problems such as nausea when they took folic acid or folinic acid with their MTX. </p> <p>Liver problems (as measured by abnormal liver blood tests):</p> <p>‐ 16 fewer people out of 100 had liver problems up to 6 to 12 months after they starting folic acid or folinic acid with their MTX (16.0% absolute improvement); </p> <p>‐ 21 people out of 100 experienced abnormal liver blood tests when they took MTX alone for their rheumatoid arthritis; </p> <p>‐ 5 people out of 100 experienced abnormal liver blood tests when they took folic acid or folinic acid with their MTX. </p> <p>Ability to continue on MTX treatment:</p> <p>‐ 15 fewer people out of 100 who took folic acid or folinic acid dropped out of the studies for any reason (15.2% absolute improvement); </p> <p>‐ 25 people out of 100 who took a placebo (fake folic acid or folinic acid) with their MTX dropped out of the studies for any reason; </p> <p>‐ 10 people out of 100 who took folic acid or folinic acid with their MTX dropped out of the studies for any reason. </p> <p>Mouth sores or ulcers:</p> <p>‐ 6 fewer people out of 100 who took folic acid or folinic acid with their MTX developed mouth sores (6.2% absolute improvement); </p> <p>‐ 22 people out of 100 who took a placebo (fake folic acid) with their MTX developed mouth sores or ulcers; </p> <p>‐ 16 people out of 100 who took folic acid or folinic acid with their MTX developed mouth sores or ulcers. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD000951-sec-0100" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD000951-sec-0100"></div> <h3 class="title" id="CD000951-sec-0101">Implications for practice</h3> <section id="CD000951-sec-0101"> <p>Our results support the protective effect of low doses of folic or folinic acid supplementation in reducing GI and liver side effects of MTX in rheumatoid arthritis patients as well as in reducing patient discontinuation of MTX therapy. </p> </section> <h3 class="title" id="CD000951-sec-0102">Implications for research</h3> <section id="CD000951-sec-0102"> <p>A multicentre RCT comparing both folate compounds and including an economic analysis may be necessary to adequately assess potential differences between the drugs. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD000951-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD000951-sec-0050"></div> <div class="table" id="CD000951-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Folic or folinic acid (any) compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Folic acid or folinic acid (any) compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients receiving methotrexate for rheumatoid arthritis<br/> <b>Settings:</b> International hospital and clinic settings<br/> <b>Intervention:</b> Supplementation with either folic or folinic acid<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Supplementation with either folic or folinic acid</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>GI side effects (nausea, vomiting, abdominal pain)</b> </p> <p>Follow‐up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>346 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>256 per 1000</b> <br/> (204 to 318) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.74</b> (0.59 to 0.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>644<br/> (6 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction: ‐9.0% (‐14.2% to ‐2.8%) (P = 0.008)</p> <p>Relative risk reduction: ‐26.0% (‐41.0% to ‐8.1%)</p> <p>NNT: 11 (7 to 35)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stomatitis / mouth sores (incidence)</b> </p> <p>Follow‐up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>223 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>161 per 1000</b> <br/> (109 to 236) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.72</b> (0.49 to 1.06) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>575<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk difference: ‐6.2% (‐11.4% to +1.3%)</p> <p>Relative risk difference: ‐27.8% (‐51.1% to +5.8%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Liver toxicity (incidence of transaminase elevation)</b> </p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>208 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b> <br/> (31 to 71) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.23</b> (0.15 to 0.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>551<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction: ‐16.0% (‐17.7% to ‐13.7%) (P &lt;0.00001)</p> <p>Relative risk reduction: ‐76.9% (‐85.1% to ‐65.9%)</p> <p>NNT: 6 (6 to 7)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Haematological disorders</b> (neutropenia, etc) </p> <p>Follow up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>&lt;10 per 1000</b><sup>2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.55</b> (0.40 to 5.91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>443<br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This is a rare event<sup>2</sup>. The studies included in this review were underpowered to detect a meaningful difference in rates of neutropenia. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total withdrawals</b> </p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>98 per 1000</b> <br/> (70 to 133) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.39</b> (0.28 to 0.53) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>640<br/> (6 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction: ‐15.2% (‐18.0% to ‐11.7%) (P &lt;0.00001)</p> <p>Relative risk reduction: ‐60.8% (‐72.0% to ‐46.8%)</p> <p>NNT: 7 (6 to 9)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of swollen joints</b> </p> <p>Change in number of swollen joints</p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of swollen joints per patient in the control group is <b>18.24</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of swollen joints per patient = <b>18.47</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>142 patients (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardized Mean Difference (SMD)</p> <p>between groups in number of swollen joints = 0.05 (‐0.28 to 0.38)</p> <p>Absolute risk difference: 4.82% (‐27.01% to 36.6%)</p> <p>Relative risk difference: 26.42% (‐148.08% to 201.04%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of tender joints</b> </p> <p>Change in number of tender joints</p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of tender joints per patient in the control group is <b>15.23</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of tender joints per patient = <b>16.05</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>122 patients</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardized Mean Difference (SMD)</p> <p>between groups in number of tender joints = 0.09 (‐0.27 to 0.45)</p> <p>Absolute risk difference: 4.55% (‐13.65% to 22.75%)</p> <p>Relative risk difference: 29.88% (‐89.63% to 149.38%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; NNT; number needed to treat </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Number of events is less than 300. </p> <p><sup>2</sup>The incidence of clinically important cytopenia in patients treated with low‐dose MTX is estimated to be less than 1%. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000951-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Folic acid compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Folic acid compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients receiving methotrexate for rheumatoid arthritis<br/> <b>Settings:</b> International hospital and clinic settings<br/> <b>Intervention:</b> Supplementation with folic acid<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Folic Acid</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>GI side effects (ie, incidence of nausea, vomiting, abdominal pain)</b> <br/> <br/> Follow‐up: 24 to 52 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>346 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>263 per 1000</b> <br/> (197 to 349) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.76</b> (0.57 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>355<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk difference = ‐8.3% (‐14.9% to 0.3%)</p> <p>Relative risk difference = ‐24.0% (‐43.1% to 0.8%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Stomatitis / mouth sores (incidence)</b> </p> <p>Follow‐up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>223 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>201 per 1000</b> </p> <p>(118 to 343)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.90</b> (0.53 to 1.54) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>302</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Absolute risk difference = ‐2.2% (‐10.5% to 12.0%)</p> <p>Relative risk difference = ‐9.9% (‐47.1% to 53.8%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Liver toxicity (ie, incidence of transaminase elevation)</b> </p> <p>Follow‐up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>208 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b> <br/> (21 to 75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.19</b> (0.10 to 0.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>302<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction = ‐16.8% (‐18.7% to ‐13.3%)</p> <p>(P &lt; 0.00001)</p> <p>Relative risk reduction = ‐80.8% (‐89.9% to ‐63.9%)</p> <p>NNT = 6 (5 to 8)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Haematological disorders</b> (incidence of neutropenia, etc) </p> <p>Follow up: 24 to 48 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>&lt;10 per 1000</b><sup>3</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.70</b> </p> <p>(0.42 to 6.96)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>443</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This is a rare event<sup>3</sup>. The studies included in this review were underpowered to detect a meaningful difference in rates of neutropenia. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total withdrawals</b> </p> <p>Follow‐up: 24 to 48 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000*</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>108 per 1000</b> <br/> (73 to 160) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.43</b> <br/> (0.29 to 0.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>343<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction = ‐14.2% (‐17.7% to ‐9.0%)</p> <p>(P=0.000039)</p> <p>Relative risk difference = ‐56.8% (‐70.8% to ‐36.0%)</p> <p>NNT = 7 (6 to 11)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of swollen joints with folic acid (</b> ≤<b>7 mg/wk)</b> <br/> Change in number of swollen joints </p> <p>Follow‐up: 48 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of swollen joints per patient = <b>16.00</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of swollen joints per patient = <b>14.35</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference between groups in number of swollen joints (Absolute difference)= ‐1.65 (‐7.96 to 4.66)<sup>4</sup> </p> <p>Relative risk difference: ‐10.4% (‐49.8% to 29.1%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of tender joints with folic acid (</b> ≤<b>7 mg/wk)</b> <br/> Change in number of tender joints </p> <p>Follow‐up: 48 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of tender joints per patient = <b>17.63</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of tender joints per patient = <b>20.09</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference between groups in number of tender joints = 2.46 (‐6.08 to 11.00)<sup>5</sup> </p> <p>Absolute risk difference:</p> <p>Relative risk difference: 14.0% (‐34.5% to 62.4%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; R<b>R:</b> Risk ratio; <b>NNT</b>: Number needed to treat </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Number of events is less than 300 </p> <p><sup>2</sup> Less than 400 participants </p> <p><sup>3</sup>The incidence of clinically important cytopenia in patients treated with low dose MTX is estimated to be less than 1%. </p> <p><sup>4</sup> Post‐treatment number of swollen joints not reported. Change scores presented here. </p> <p><sup>5</sup> Post‐treatment number of tender joints not reported. Change scores presented here. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD000951-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Folinic acid compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Folinic acid compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients receiving methotrexate for rheumatoid arthritis<br/> <b>Settings:</b> International hospital and clinic settings<br/> <b>Intervention:</b> Supplemtation with folinic acid<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Folinic Acid</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>GI side effects (nausea, vomiting, abdominal pain)</b> </p> <p>Follow‐up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>346 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>270 per 1000</b> <br/> (204 to 353) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.78</b> (0.59 to 1.02) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>426<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk difference: ‐7.6% (‐14.2% to 0.7%)</p> <p>Relative risk difference: ‐22.0% (‐41.0 to 2.0%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Stomatitis / mouth sores (incidence)</b> </p> <p>Follow‐up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>223 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>156 per 1000</b> </p> <p>(103 to 239)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.70</b> (0.46 to 1.07) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>410 (3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Absolute risk difference: ‐6.7% (‐12.0% to 0.16%)</p> <p>Relative risk difference: ‐30.0% (‐53.8% to 7.2%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Liver toxicity (incidence of transaminase elevation)</b> </p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>208 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 1000</b> <br/> (33 to 92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.27</b> (0.16 to 0.44) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>358<br/> (3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction: ‐15.2% (‐17.5% to ‐11.6%)</p> <p>Relative risk reduction: ‐73.1% (‐84.1% to ‐55.8%)</p> <p>NNT: 7 (6 to 9)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Haematological disorders</b> (neutropenia, etc) </p> <p>Follow‐up: 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>&lt;10 per 1000</b><sup>3</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.46</b> (0.25 to 8.59) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>278</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This is a rare event<sup>3</sup>. The studies included in this review were underpowered to detect a meaningful difference in rates of neutropenia. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total withdrawals</b> </p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>88 per 1000</b> <br/> (58 to 133) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.35</b> (0.23 to 0.53) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>386<br/> (3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction: ‐16.2% (‐19.2% to ‐11.7%)</p> <p>Relative risk reduction: ‐64.8% (‐76.8% to ‐46.8%)</p> <p>NNT: 6 (5 to 9)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of swollen joints with folinic acid (</b> ≤<b>7 mg/wk)</b> <br/> Change in number of swollen joints </p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of swollen joints per patient = <b>19.13</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of swollen joints per patient = <b>20.29</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference between groups in number of swollen joints (Absolute difference) = 1.72 (‐3.47 to 6.92)<sup>4</sup> </p> <p>Relative risk difference: 8.1% (‐16.3% to 32.6%)</p> <p>Not statisticaly significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of tender joints with folinic acid (</b> ≤<b>7 mg/wk)</b> <br/> Change in number of tender joints </p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of tender joints per patient = <b>14</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of tender joints per patient = <b>13.88</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference between groups in number of tender joints (Absolute difference) = 1.13 (‐4.25 to 6.51)<sup>5</sup> </p> <p>Relative risk difference: 6.3% (‐23.9% to 36.6%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>NNT</b>; number needed to treat </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Number of events is less than 300.<br/> <sup>2</sup> Less than 400 participants. </p> <p><sup>3</sup>The incidence of clinically important cytopenia in patients treated with low‐dose MTX is estimated to be less than 1%.<br/> <sup>4</sup> Post‐treatment number of swollen joints not reported. Change scores presented here.<br/> <sup>5</sup> Post‐treatment number of tender joints not reported. Change scores presented here. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD000951-sec-0051" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD000951-sec-0051"></div> <section id="CD000951-sec-0052"> <h3 class="title" id="CD000951-sec-0052">Description of the condition</h3> <p>Rheumatoid arthritis is a chronic, systemic inflammatory disorder that can affect many tissues and organs, but principally attacks synovial joints. Rheumatoid arthritis can produce diffuse inflammation in the lungs, pericardium, pleura and sclera, and also nodular lesions, which are most common in subcutaneous tissue. Although the cause of rheumatoid arthritis is unknown, autoimmunity plays a pivotal role in both its chronicity and progression, and as such it is considered a systemic autoimmune disease. About 1% of the world's population is afflicted by rheumatoid arthritis, women three times more often than men. Onset is most frequent between the ages of 40 and 50 years, but people of any age can be affected. It can be a disabling and painful condition, which can lead to substantial loss of functioning and mobility if not adequately treated (<a href="./references#CD000951-bbs2-0037" title="MajithiaV , GeraciSA . Rheumatoid arthritis: diagnosis and management. American Journal of Medicine2007;120 (11):36–9. ">Majithia V 2007</a>). </p> <p>Methotrexate (MTX) is classified pharmacologically as an antimetabolite due to its antagonistic effect on folic acid metabolism. Although its exact mechanism of action in rheumatoid arthritis is uncertain, it has become many rheumatologists' first line drug of choice (<a href="./references#CD000951-bbs2-0035" title="KremerJ . The changing face of therapy for rheumatoid arthritis. Rheumatic Diseases Clinics of North America1995;21(3):845‐52. ">Kremer 1995</a>). The evidence for its efficacy is well documented at least over the short term. MTX has been shown to be efficacious in observational studies, showing short term clinical improvement in 48% to 90% of patients (<a href="./references#CD000951-bbs2-0052" title="TugwellP , BennettK , GentM . Methotrexate in rheumatoid arthritis. Annals of Internal Medicine1987;107:358‐66. ">Tugwell 1987</a>; <a href="./references#CD000951-bbs2-0053" title="TugwellP , BennettK , GentM . Methotrexate in rheumatoid arthritis. Feedback on American College of Physicians guidelines. Annals of Internal Medicine1989;110:581‐3. ">Tugwell 1989</a>), and in 10% to 70% of participants in placebo‐controlled studies (<a href="./references#CD000951-bbs2-0016" title="AndersenP , WestS , O'DellJ , et al. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double‐blind study. Annals of Internal Medicine1985;103:489‐96. ">Anderson 1985</a>; <a href="./references#CD000951-bbs2-0051" title="ThompsonR , WattsC , EdelmanJ , et al. A controlled two‐centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. Journal of Rheumatology1984;11:760‐3. ">Thompson 1984</a>; <a href="./references#CD000951-bbs2-0055" title="WeinblattM , CoblynJ , FoxD , et al. Efficacy of low‐dose methotrexate in rheumatoid arthritis. New England Journal of Medicine1985;312:818‐22. ">Weinblatt 1985</a>; <a href="./references#CD000951-bbs2-0056" title="WilliamsH , WilkensR , SamuelsonC , et al. Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis and Rheumatism1985;28:721‐30. ">Williams 1985</a>). Three meta‐analyses (<a href="./references#CD000951-bbs2-0025" title="FelsonD , AndersonJ , MeenanR . The comparative efficacy and toxicity of second‐line drugs in rheumatoid arthritis. Results of two meta‐analyses. Arthritis and Rheumatism1990;33(10):1449‐61. ">Felson 1990</a>; <a href="./references#CD000951-bbs2-0050" title="Suarez‐AlmazorME , BelseckE , SheaB , TugwellP , WellsGA . Methotrexate for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews1998, Issue 2. [DOI: 10.1002/14651858.CD000957] ">Suarez‐Almazor 1998</a>; <a href="./references#CD000951-bbs2-0052" title="TugwellP , BennettK , GentM . Methotrexate in rheumatoid arthritis. Annals of Internal Medicine1987;107:358‐66. ">Tugwell 1987</a>) estimate that a third of the patients show a major improvement. Methotrexate is often used in combination with other disease modifying drugs and biologics (<a href="./references#CD000951-bbs2-0033" title="KatchamartW , TrudeauJ , PhumethumV , BombardierC . Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis. Cochrane Database of Systematic Reviews2010;4:pp CD008495. ">Katchamart 2010</a>; <a href="./references#CD000951-bbs2-0038" title="MaxwellL , SinghJ . Abatacept for rheumatoid arthritis. Cochrane Database of Systematic Reviews2009;4:pp CD007277. ">Maxwell 2009</a>; <a href="./references#CD000951-bbs2-0042" title="Navarro SabiaF , Ariza ArizaR , Hernandez CruzB , VillanuevaI . Adalimumab for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews2005, Issue 3. [DOI: 10.1002/14651858.CD005113.pub2] ">Navarro Sarabia 2005</a>; <a href="./references#CD000951-bbs2-0047" title="SinghJ , ChristensenR , WellsG , Suarez AlamorM , BuchbinderR , Lopez OlivoA , Tanjong GhogomuE , TugwellP . Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews2009, Issue 4. [DOI: 10.1002/14651858.CD007848.pub2] ">Singh 2009</a>). Felson also compared the benefit‐toxicity trade offs of various second line drugs and ranked MTX ahead of azathioprine, sulfasalazine, gold salts and penicillamine (<a href="./references#CD000951-bbs2-0026" title="FelsonD , AndersonJ , MeenanR . Use of short‐term efficacy/toxicity tradeoffs to select second‐line drugs in rheumatoid arthritis: A meta‐analysis of published clinical trials. Arthritis and Rheumatism1992;35:1117‐25. ">Felson 1992</a>). However, toxicity does prevent many patients from obtaining benefit from the drug. It has been reported that mild toxicity occurs in about 60% of patients, and roughly 7% to 30% of patients discontinue MTX therapy within the first year of treatment due to toxicity (<a href="./references#CD000951-bbs2-0035" title="KremerJ . The changing face of therapy for rheumatoid arthritis. Rheumatic Diseases Clinics of North America1995;21(3):845‐52. ">Kremer 1995</a>; <a href="./references#CD000951-bbs2-0045" title="SchnabelA , GrossWl . Low‐dose methotrexate in rheumatic diseases: efficacy, side effects and risk factors for side effects. Seminars in Arthritis and Rheumatism1994;23:310‐27. ">Schnabel 1994</a>). </p> </section> <section id="CD000951-sec-0053"> <h3 class="title" id="CD000951-sec-0053">Description of the intervention</h3> <p>Folic acid (also known as vitamin B9) has demonstrated health benefits in a variety of areas. Folinic acid (5‐formyl tetrahydrofolate) is one active form in the group of vitamins known as folates. In contrast to folic acid (which is a synthetic form of folate) folinic acid is one of the forms of folate found naturally in foods. In the body folinic acid can be converted into any of the other active forms of folate. </p> </section> <section id="CD000951-sec-0054"> <h3 class="title" id="CD000951-sec-0054">How the intervention might work</h3> <p>Both MTX dose and length of exposure influence toxicity relating to MTX treatment (<a href="./references#CD000951-bbs2-0054" title="WallaceC , SherryD . A practical to avoidance of methotrexate toxicity [Editorial]. Journal of Rheumatology1995;22(6):1009‐12. ">Wallace 1995</a>). Other predisposing factors include existing folate deficiency, advanced age, cumulative dose, renal insufficiency and concomitant use of other antifolates (<a href="./references#CD000951-bbs2-0032" title="JacksonR . Biological effects of folic acid antagonists with antineoplastic activity. Pharmacology &amp; Therapeutics1984;25:61‐82. ">Jackson 1984</a>). Depleted intracellular folate levels have been documented in hepatocytes and peripheral blood lymphocytes of MTX treated patients (<a href="./references#CD000951-bbs2-0034" title="KremerJ , GalivanJ , StreckfussA , KamenB . Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. Arthritis and Rheumatism1986;29:832‐4. ">Kremer 1986</a>; <a href="./references#CD000951-bbs2-0036" title="LeebBF , WitzmannG , OgrisE , Studnicka‐BenkeA , AndelI , SchweitzerH , SmolenJS . Folic acid and cyanocobalamin levels in serum and erythrocytes during low‐dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients. Clinical and Experimental Rheumatology1995 Jul‐Aug;13(4):459‐63. ">Leeb 1995</a>; <a href="./references#CD000951-bbs2-0039" title="MorganS , BaggotJ , Altz‐SmithM . Folate status of rheumatoid arthritis patients receiving long‐term, low‐dose methotrexate therapy. Arthritis and Rheumatism1987;30:1348‐56. ">Morgan 1987</a>; <a href="./references#CD000951-bbs2-0040" title="MorganS , BaggotJ , RefsumH , UelandP . Homocysteine levels in patients with rheumatoid arthritis treated with low‐dose methotrexate. Clinical Pharmacology and Therapeutics1991;50:547‐56. ">Morgan 1991</a>; <a href="./references#CD000951-bbs2-0049" title="StengerA , HoutmanP , BruynG . Does folate supplementation make sense in patients with rheumatoid arthritis treated with methotrexate?. Annals of the Rheumatic Diseases1992;51:1019‐20. ">Stenger 1992</a>; <a href="./references#CD000951-bbs2-0013" title="StewartK , MackenzieA , CloughJ , WilkeW . Folate supplementation in methotrexate‐treated rheumatoid arthritis patients. Seminars in Arthritis and Rheumatism1991;20(5):332‐8. ">Stewart 1991</a>). Folate deficiency occurs frequently in patients with rheumatoid arthritis, and folate stores are further decreased in patients with rheumatoid arthritis who receive MTX (<a href="./references#CD000951-bbs2-0036" title="LeebBF , WitzmannG , OgrisE , Studnicka‐BenkeA , AndelI , SchweitzerH , SmolenJS . Folic acid and cyanocobalamin levels in serum and erythrocytes during low‐dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients. Clinical and Experimental Rheumatology1995 Jul‐Aug;13(4):459‐63. ">Leeb 1995</a>). Gastrointestinal and haematologic side effects have been related to folate deficiency. Therefore, it could be expected that folate supplementation may reduce side effects associated with MTX therapy. </p> <p>There has been concern that folate supplementation may reduce the efficacy of, and therefore benefit seen with, MTX if the antirheumatic effects are also mediated through folate antagonism. It has been suggested that since the mechanism of action of MTX in rheumatoid arthritis is not fully known, the beneficial effect of folate supplementation could be the result of a relative reduction of the dose of MTX (<a href="./references#CD000951-bbs2-0049" title="StengerA , HoutmanP , BruynG . Does folate supplementation make sense in patients with rheumatoid arthritis treated with methotrexate?. Annals of the Rheumatic Diseases1992;51:1019‐20. ">Stenger 1992</a>). Several open prospective studies and randomised controlled trials (RCTs) have been conducted to determine if folate supplementation, with folic acid or folinic acid, has a beneficial effect in reducing the frequency and severity of MTX side effects, and to investigate potential changes to the therapeutic benefit. It is thought folate supplementation could therefore help 'rescue' or reverse the toxic effects of MTX. </p> </section> <section id="CD000951-sec-0055"> <h3 class="title" id="CD000951-sec-0055">Why it is important to do this review</h3> <p>These studies have produced varying estimates of the reduction in adverse effects, ranging from 0% to 50%. Clinicians and patients need to have a 'best estimate' to make informed decisions on whether to use folate supplementation; therefore, a meta‐analysis was undertaken. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD000951-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD000951-sec-0056"></div> <p> <ul id="CD000951-list-0001"> <li> <p>To examine the effect of low doses of folic acid and folinic acid in reducing gastrointestinal, hepatic (liver toxicity) and haematologic side effects of low dose MTX in patients with rheumatoid arthritis. </p> </li> <li> <p>To determine if folate supplementation with folic acid or folinic acid reduces the arthritis benefit of MTX therapy. </p> </li> </ul> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD000951-sec-0057" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD000951-sec-0057"></div> <section id="CD000951-sec-0058"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD000951-sec-0059"> <h4 class="title">Types of studies</h4> <p>All double‐blind, randomised, placebo‐controlled clinical trials.</p> </section> <section id="CD000951-sec-0060"> <h4 class="title">Types of participants</h4> <p>Patients older than 18 years who fulfilled the American Rheumatism Association's criteria for rheumatoid arthritis (<a href="./references#CD000951-bbs2-0017" title="ArnettF , EdworthyS , BlochD , et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis and Rheumatism1988;31:315‐24. ">Arnett 1988</a>). </p> </section> <section id="CD000951-sec-0061"> <h4 class="title">Types of interventions</h4> <p>Treatment with low doses of MTX (equal or less than 25 mg/week) concurrently with low dose folate supplementation (either folic or folinic acid), with a starting dose equal to or less than 7 mg/week. </p> </section> <section id="CD000951-sec-0062"> <h4 class="title">Types of outcome measures</h4> <section id="CD000951-sec-0063"> <h5 class="title">Major outcomes</h5> <p>Results relating to at least one of the following: gastrointestinal symptoms (such as nausea, vomiting or abdominal pain), mouth ulcers (stomatitis), liver toxicity (as measured by raised serum transaminases), haematologic side effects (anaemia or cytopenia), or withdrawal or discontinuation of MTX therapy. </p> </section> <section id="CD000951-sec-0064"> <h5 class="title">Minor outcomes</h5> <p>Alteration of the beneficial effect of MTX (loss of efficacy) as measured by any of the following. </p> <p> <ul id="CD000951-list-0002"> <li> <p>Swollen joint count.</p> </li> </ul> <ul id="CD000951-list-0003"> <li> <p>Tender joint count.</p> </li> </ul> <ul id="CD000951-list-0004"> <li> <p>Pain.</p> </li> </ul> <ul id="CD000951-list-0005"> <li> <p>Disability score.</p> </li> </ul> <ul id="CD000951-list-0006"> <li> <p>Grip strength.</p> </li> </ul> <ul id="CD000951-list-0007"> <li> <p>Patient's global assessment.</p> </li> </ul> <ul id="CD000951-list-0008"> <li> <p>Physician's global assessment.</p> </li> </ul> </p> </section> </section> </section> <section id="CD000951-sec-0065"> <h3 class="title">Search methods for identification of studies</h3> <p>In the first version of the review, to identify trials of supplementation with folic acid or folinic acid during MTX therapy for rheumatoid arthritis we performed MEDLINE searches from January 1966 to June 1999. We also searched the Controlled Clinical Trials Register (CCTR) Issue 2, 1999 and the Cochrane Musculoskeletal Group's specialized register. We used the strategy developed by The Cochrane Collaboration as well as the search adopted and modified for the Cochrane Musculoskeletal Group (<a href="./references#CD000951-bbs2-0021" title="DickersinK , SchererR , LefebvreC . Identifying relevant studies for systematic reviews. BMJ1994;309:1286‐91. ">Dickersin 1994</a>). </p> <p>This computer search was complemented by the following handsearches: (i) bibliographic references, (ii) Current Contents from June to December 1996, (iii) abstracts of rheumatology meetings from 1993 to 1996: American College of Rheumatology, International League Against Rheumatism, British College of Rheumatologists, Canadian College of Rheumatologists and European League Against Rheumatism, (iv) all issues of the four journals: Journal of Rheumatology, Arthritis and Rheumatism, Clinical and Experimental Rheumatology, and British Journal of Rheumatology from January 1992 to April 1996. </p> <p>As part of the update of this review, a sensitive search strategy was designed to retrieve all trials on folic acid or folinic acid for rheumatoid arthritis from 1999 to March 2012. We did not limit the search by language. We searched the following databases:  </p> <p>1. <i>The Cochrane Library</i> 2012, Issue 2<i>,</i> Wiley InterScience (www.thecochranelibrary.com) including the Cochrane Central Register of Controlled Trials (CENTRAL), Database of Reviews of Effectiveness (DARE), HTA database, NHS EED, and the Methods Studies database; </p> <p>2. MEDLINE (via Ovid), 1999 to February week 4, 2012;</p> <p>3. MEDLINE® In‐Process &amp; Other Non‐Indexed Citations (via Ovid), 2 March 2012;</p> <p>4. EMBASE, 1999 to Week 9 ‐2012;</p> <p>5. NIH clinical trials registry Clinical Trials.gov.</p> <p>The search strategy was devised on Ovid MEDLINE (<a href="./appendices#CD000951-sec-0106">Appendix 1</a>) and then adapted for the other databases (<a href="./appendices#CD000951-sec-0107">Appendix 2</a>; <a href="./appendices#CD000951-sec-0108">Appendix 3</a>). In all cases the databases were searched from 1999 to 2 March 2012. All references were imported into an EndNote library and tagged with the name of the database.  </p> </section> <section id="CD000951-sec-0066"> <h3 class="title" id="CD000951-sec-0066">Data collection and analysis</h3> <section id="CD000951-sec-0067"> <h4 class="title">Selection of studies</h4> <p>Following an a priori protocol, at least two review authors (BS, ZO, WK, MS, TR) independently reviewed the eligibility criteria for abstracts for inclusion in this review. We screened all titles or abstracts generated by the searches for potentially relevant studies based on the following criteria: the type of study; type of participants; type of intervention; and type of outcome measurements. We assessed the full‐length articles of the selected titles or abstracts for eligibility (for a full description see 'Criteria for considering studies for this review'). We resolved disagreements by consensus or third‐party adjudication. </p> </section> <section id="CD000951-sec-0068"> <h4 class="title">Data extraction and management</h4> <p>Data were independently extracted by four authors (ZO, BS, WK, MS). Folate supplementation was considered as 'the administration of folic or folinic acid in any dose, and at any time with respect to MTX'. The following gastrointestinal effects were combined (where possible) because of lack of consistency in the reporting and to obtain sufficient events for analysis: abdominal pain, anorexia, dyspepsia, nausea and vomiting. The incidence of stomatitis as well as the incidence of abnormal serum liver enzymes were analysed independently. The included studies had defined 'abnormal liver function test' differently, and for data extraction purposes we defined 'abnormal' as either aspartate aminotransferase (AST), alanine aminotransferase (ALT) or alkaline phosphatase (ALP) at least equal to or greater than two times baseline values, or at least two times the upper limit of the reference range used in the study. The following haematologic side effects were included, if reported: cytopenia, macrocytosis, or pancytopenia. </p> <p>To assess changes in disease activity, the following measurements were considered a priori: swollen joint count, tender joint count, pain, disability score, grip strength, patient's global assessment, and physician's global assessment. Most trials reported swollen and tender joint counts, or indices, and patient global assessments. These were the outcomes finally included for the MTX efficacy analysis. Joint counts included the number of swollen and tender joints, if reported. Alternatively, when the number of involved joints was not reported indices (for example Ritchie index) were included. </p> <p>A starting dose of ≤ 7 mg/wk folic or folinic acid was used as a cut off value for studies to be included in the analysis. The aim of this was to exclude studies which gave very high doses of folic or folinic acid. It was felt by the authors that by doing so, it would allow the results of the updated review to provide a better estimate of the effects of folate supplementation at doses currently prescribed in practice. Worldwide guidelines currently support co‐administration of folic acid with MTX, and where a dose value is suggested it usually falls in the range of 0.5 to 2 mg daily (<a href="./references#CD000951-bbs2-0019" title="ChakravartyK , McDonaldH , PullarT , TaggartA , ChalmersR , OliverS , et al. BSR/BHPR guideline for disease‐modifying anti‐rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists. Rheumatology2008;47(6):924‐5. [PUBMED: 16940305] ">Chakravarty 2008</a>; <a href="./references#CD000951-bbs2-0024" title="Dutch Society of Rheumatology. Guidelines for Medication: Methotrexate [Nederlandse Vereniging voor Reumatologie. Richtlijnen Medicijnen: Methotrexaat]. Available via http://www.nvr.nl/richtlijnen/Totstandkoming_richtlijnen September 2009 (Updated 2011). ">Dutch Society of Rheumatology 2011</a>; <a href="./references#CD000951-bbs2-0028" title="GUIPCAR Group. Clinical practice guideline for the management of rheumatoid arthritis in Spain. Spanish Society of Rheumatology, Madrid2007:301. ">GUIPCAR group 2007</a>; <a href="./references#CD000951-bbs2-0048" title="SinghJA , FurstDE , BharatA , CurtisJR , KavanaughAF , KremerJM , MorelandLW . 2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease‐Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis. Arthritis Care and ResearchMay 2012;64(5):625‐39. [PUBMED: 22473917] ">Singh 2012</a>). </p> </section> <section id="CD000951-sec-0069"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Assessment of risk of bias was undertaken for each included study using the Cochrane Collaboration's 'Risk of bias' tool (<a href="./references#CD000951-bbs2-0031" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). The following seven key domains were assessed by two review authors: sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete outcome data, selective outcome reporting and 'other issues' (comparability of treatment and control group at entry, and appropriateness of duration of surveillance). Pairs of review authors judged the key domains as either 'high risk', 'low risk' or 'unclear' rsk of bias. In cases of disagreement between the review authors, the decision was made by consensus. </p> </section> <section id="CD000951-sec-0070"> <h4 class="title">Measures of treatment effect</h4> <p>For each trial, risk ratio and the 95% confidence interval were calculated for dichotomous outcomes. Data analysis employed a standard meta‐analysis using methods for continuous data developed by Hedges and Olkin (<a href="./references#CD000951-bbs2-0030" title="HedgesLV . Estimation of effect size from a series of independent experiments. Psychological Bulletin1982;92:490‐499. ">Hedges 1982</a>) and described by Petitti (<a href="./references#CD000951-bbs2-0043" title="PetittiD . Meta‐analysis, decision analysis, and cost‐effectiveness analysis: methods for quantitative synthesis in medicine. First Edition. New York: Oxford University Press, 1994:90‐114. ">Petitti 1994</a>). Mean differences (MD) and 95% confidence intervals (CIs) were calculated for continuous outcomes (reporting mean and standard deviation or standard error of the mean). If the scale for each assessment varied among the studies and the mean and standard deviation of the change was provided for the folic and folinic acid arm and control arm, we calculated a standardised mean difference. If the standard deviations of the change scores were not available we used the standard deviation of the baseline score for each group. This provides a conservative estimate of the significance of differences between groups. </p> </section> <section id="CD000951-sec-0071"> <h4 class="title">Unit of analysis issues</h4> <p>The level at which randomisation occurred in the included studies was reported as specified by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD000951-bbs2-0020" title="DeeksJJ , HigginsJPT , Altman DG (editors). The Cochrane Collaboration, 2011 . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT,Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). </p> </section> <section id="CD000951-sec-0072"> <h4 class="title">Dealing with missing data</h4> <p>If we noticed missing data during data extraction we attempted to contact the original investigators of the study to request the required information. It was anticipated that it may also have been necessary to conduct a sensitivity analysis if assumptions were made (<a href="./references#CD000951-bbs2-0020" title="DeeksJJ , HigginsJPT , Altman DG (editors). The Cochrane Collaboration, 2011 . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT,Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). The potential effect of missing data upon conclusions drawn from this review would also be described. </p> </section> <section id="CD000951-sec-0073"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity between comparable trials was tested using a standard Chi<sup>2</sup> test and considered statistically significant at P &lt; 0.10 after due consideration of the value of the I<sup>2</sup> statistic, a value greater than 50% may indicate substantial heterogeneity. If results were determined to be heterogeneous (that is I<sup>2</sup> &gt; 50%) a random‐effects model would have been used to further analyse the results. </p> </section> <section id="CD000951-sec-0074"> <h4 class="title">Assessment of reporting biases</h4> <p>If there were sufficient studies it was intended to assess the possibility of publication bias with funnel plots.  </p> </section> <section id="CD000951-sec-0075"> <h4 class="title">Data synthesis</h4> <p>Where appropriate, results of comparable groups of trials were pooled using the fixed‐effect model and 95% CIs were calculated. If heterogeneity existed between studies a random‐effects model was to be used however there was no heterogeneity between included trials. </p> <p>Since folic and folinic acid do not act at the same point on the folate pathway, they were analysed separately as well as together. For side effects, the overall treatment effect across trials was calculated using a fixed‐effect model (Mantel‐Haenszel). </p> <p>Meta‐analysis was facilitated by RevMan 5.2 using the statistics as described below.</p> <p><b>Continuous outcomes</b><i> </i> </p> <p>The trials included in this review used different indices to evaluate changes in disease activity. For instance, different total numbers of joints were considered and global assessments were measured with various scales. To enhance comparability across trials all the disease activity outcome variables (joint counts and patient global assessments) were compared using standardised mean differences between the treatment (folic or folinic acid) and placebo groups. The standardised mean differences were based on end‐of‐trial results. When appropriate, the standardised mean differences were pooled by applying the inverse of the variance of each trial as a weight. </p> <p>Mean differences (MD) were calculated using a fixed‐effect model as outcomes were measured on the same standard scales. </p> <p><b>Dichotomous outcomes</b>  </p> <p>Risk ratio (RR) (Mantel‐Haenszel) and 95% CI were calculated for dichotomous outcomes. A fixed‐effect model was selected for interpretation of the dichotomous outcome measures in this review since this is the most appropriate statistic for the interpretation of pooled data where the event is common (<a href="http://archie.cochrane.org/sections/documents/view?document=019899092814182934%26format=REVMAN#REF-Deeks-1998" target="_blank">Deeks 1998</a>) and where there is no significant statistical heterogeneity between trials. </p> <p>Additional data were obtained from the authors for one of the studies. Another study did not report any measures of dispersion. The end‐of‐trial variance for this study was estimated using the mean coefficient of variation of the other trials weighted by the sample size of each study. The pooled estimates were calculated using RevMan 5.1. The analysis was conducted separately for folic and folinic acid and pooled. </p> <p>Appropiate statistical analysis was performed using RevMan in accordance with the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD000951-bbs2-0020" title="DeeksJJ , HigginsJPT , Altman DG (editors). The Cochrane Collaboration, 2011 . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT,Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). </p> </section> <section id="CD000951-sec-0076"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>In the presence of significant heterogeneity, the results from comparable groups of trials were pooled using the random‐effect model and the 95% CIs calculated. </p> </section> <section id="CD000951-sec-0077"> <h4 class="title">Sensitivity analysis</h4> <p>We anticipated that sensitivity analyses would be undertaken, when indicated, to investigate the effects of methodological quality, for example allocation concealment and intention‐to‐treat analysis or where cluster randomised trials were combined with each other or with other studies in a meta‐analysis. </p> <section id="CD000951-sec-0078"> <h5 class="title">Grading of evidence and summary of findings table</h5> <p>Major outcomes (including benefits and adverse events) were presented in <a href="./full#CD000951-tbl-0001">summary of findings Table for the main comparison</a>, <a href="./full#CD000951-tbl-0002">summary of findings Table 2</a> and <a href="./full#CD000951-tbl-0003">summary of findings Table 3</a>, which provide information on the quality of evidence and the magnitude of the intervention effect, as well as a summary of the main outcome data (<a href="./references#CD000951-bbs2-0046" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011</a>). An assessment of the overall quality of evidence per outcome (high, moderate, low and very low) using the GRADE approach was also presented as outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD000951-bbs2-0046" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011</a>). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD000951-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD000951-sec-0079"></div> <section id="CD000951-sec-0080"> <h3 class="title">Description of studies</h3> <section id="CD000951-sec-0081"> <h4 class="title">Results of the search</h4> <p>We initially screened 133 references as well as an additional 192 during the update, from which 15 papers in total were selected for full text appraisal. </p> <p>Six RCTs met the eligibility criteria. The other nine (two abstracts and seven articles) were excluded. </p> <p>All of the RCTs included in the analysis assessed haematologic side effects with a complete blood count including platelet count. Some trials also included mean corpuscular volume. Three of six included trials reported the results as 'there was no statistically significant difference in the frequency of haematologic side effects between folate group and placebo group'. Hence, they did not report the number of patients with haematologic side effects, mean values or measures of variance and could not be included in the analysis. Overall, the included trials reported 624 participants of which 385 were treated with either folinic (211 participants) or folic acid (174 participants). </p> <p>See the study flow diagram (<a href="#CD000951-fig-0001">Figure 1</a>) and search summary (<a href="#CD000951-tbl-0004">Table 1</a>). </p> <div class="figure" id="CD000951-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD000951-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <div class="table" id="CD000951-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Search summary</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Database(s)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Search Date</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results (n=)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Notes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MEDLINE (1966‐1999), CCTR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>January 1966‐June 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133 after duplicates removed</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MEDLINE, PubMed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1999 ‐ June 2011</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See footnote<sup>1</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MEDLINE, PubMed, EMBASE, CENTRAL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1999‐March 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>192 after duplicates removed</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total after duplicates removed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>1</sup>In 2011 this review was assessed as suitable for a 'streamlined' update search procedure. A Boolean serach of intervention and condition terms was combined with a Randomised Controlled Trial filter from 1999 until June 2011. A Pubmed 'related items' search was also carried out of the 3 largest and 3 most recent included studies from the original review. </p> <p>During the 2012 review, the search was re‐run, and back‐dated to follow on from the original search (1999). </p> </div> </div> </section> <section id="CD000951-sec-0082"> <h4 class="title">Included studies</h4> <p>Six RCTs met the updated eligibility criteria (<a href="./references#CD000951-bbs2-0001" title="BuckleyL , VacekP , CooperS . Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. Journal of Rheumatology1990;17:1158‐61. ">Buckley 1990</a>; <a href="./references#CD000951-bbs2-0002" title="MorganSL , BaggottJ , VaughnW , YoungP , AustinJ , KrumdieckC , AlarconS . The effect of folic acid supplementation on the toxicity of low‐dose methotrexate in patients with rheumatoid arthritis. Arthritis and Rheumatism1990;33(1):9‐18. ">Morgan 1990</a>; <a href="./references#CD000951-bbs2-0003" title="MorganS , BaggotJ , VaughnW , et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double‐blind, placebo controlled trial. Annals of Internal Medicine1994;121(11):833‐41. ">Morgan 1994</a>; <a href="./references#CD000951-bbs2-0004" title="ShirokyJ , NevilleC , EsdaileJ , et al. Low dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a randomized, double‐blind, placebo controlled trial. Arthritis and Rheumatism1993;36(3):795‐803. ">Shiroky 1993</a>; <a href="./references#CD000951-bbs2-0005" title="VanEdeA , LaanR , BlomH , HuizingaT , HaagsmaC , GiesendorfB , et al. The C677T mutation in the methylenetetrahydrofolate reductase gene. A genetic risk factor for methotrexate‐related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis and Rheumatism2001;44(11):2525‐30. ">Van Ede 2001</a>; <a href="./references#CD000951-bbs2-0006" title="WeinblattM , MaierA , CoblynJ . Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 weeks randomized placebo controlled trial. Journal of Rheumatology1993;20:950‐2. ">Weinblatt 1993</a>). </p> <p><a href="./references#CD000951-bbs2-0003" title="MorganS , BaggotJ , VaughnW , et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double‐blind, placebo controlled trial. Annals of Internal Medicine1994;121(11):833‐41. ">Morgan 1994</a> evaluated two different doses of folic acid and only the patients given a dose of folate within our criteria for acceptance were included in this meta‐analysis. In the trial by <a href="./references#CD000951-bbs2-0001" title="BuckleyL , VacekP , CooperS . Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. Journal of Rheumatology1990;17:1158‐61. ">Buckley 1990</a> patients received folinic acid at a dose which varied according to their MTX dose. The mean MTX dose was 9.9 mg/wk (5 to 15 mg/wk). The side effects were not reported separately for patients at above and below 7 mg/wk folinic acid but we decided to include it in the analysis. The inclusion of this study did not change the overall results substantially. </p> <p>In the trial by <a href="./references#CD000951-bbs2-0005" title="VanEdeA , LaanR , BlomH , HuizingaT , HaagsmaC , GiesendorfB , et al. The C677T mutation in the methylenetetrahydrofolate reductase gene. A genetic risk factor for methotrexate‐related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis and Rheumatism2001;44(11):2525‐30. ">Van Ede 2001</a> patients received folic or folinic acid at a starting dose of 1 mg/day and 2.5 mg/week respectively. The MTX dose used was variable (7.5 mg to 25 mg/week). When the MTX dose increased to (or beyond) 15 mg/week the doses of folic and folinic acid were doubled. </p> <p>For details of the content of individual interventions see <a href="./references#CD000951-sec-0123" title="">Characteristics of included studies</a>. </p> </section> <section id="CD000951-sec-0083"> <h4 class="title">Excluded studies</h4> <p>Nine RCTs (two abstracts and seven articles) were excluded: two abstracts were published as full‐length publications, one trial was not double‐blind, one was uncontrolled, two did not include the outcomes of interest and three gave doses of folic or folinic acid outside the range of interest for this review (see C<a href="./references#CD000951-sec-0124" title="">haracteristics of excluded studies</a>). </p> </section> </section> <section id="CD000951-sec-0084"> <h3 class="title">Risk of bias in included studies</h3> <p>The methodological quality summary for each included study is presented in <a href="#CD000951-fig-0002">Figure 2</a> and the review authors' judgements about each methodological quality item are presented as percentages across all included studies in <a href="#CD000951-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD000951-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD000951-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> </div> <div class="figure" id="CD000951-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD000951-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD000951-sec-0085"> <h4 class="title">Allocation</h4> <p>Three studies adequately described sequence generation (low risk of bias) (<a href="./references#CD000951-bbs2-0002" title="MorganSL , BaggottJ , VaughnW , YoungP , AustinJ , KrumdieckC , AlarconS . The effect of folic acid supplementation on the toxicity of low‐dose methotrexate in patients with rheumatoid arthritis. Arthritis and Rheumatism1990;33(1):9‐18. ">Morgan 1990</a>; <a href="./references#CD000951-bbs2-0003" title="MorganS , BaggotJ , VaughnW , et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double‐blind, placebo controlled trial. Annals of Internal Medicine1994;121(11):833‐41. ">Morgan 1994</a>; <a href="./references#CD000951-bbs2-0004" title="ShirokyJ , NevilleC , EsdaileJ , et al. Low dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a randomized, double‐blind, placebo controlled trial. Arthritis and Rheumatism1993;36(3):795‐803. ">Shiroky 1993</a>). One study reported a high risk of bias as there was nothing mentioned about concealment (<a href="./references#CD000951-bbs2-0005" title="VanEdeA , LaanR , BlomH , HuizingaT , HaagsmaC , GiesendorfB , et al. The C677T mutation in the methylenetetrahydrofolate reductase gene. A genetic risk factor for methotrexate‐related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis and Rheumatism2001;44(11):2525‐30. ">Van Ede 2001</a>) and the other studies did not clearly describe these methods (unclear risk of bias). </p> </section> <section id="CD000951-sec-0086"> <h4 class="title">Blinding</h4> <p>Five studies adequately blinded participants for the intervention (low risk of bias) (<a href="./references#CD000951-bbs2-0002" title="MorganSL , BaggottJ , VaughnW , YoungP , AustinJ , KrumdieckC , AlarconS . The effect of folic acid supplementation on the toxicity of low‐dose methotrexate in patients with rheumatoid arthritis. Arthritis and Rheumatism1990;33(1):9‐18. ">Morgan 1990</a>; <a href="./references#CD000951-bbs2-0003" title="MorganS , BaggotJ , VaughnW , et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double‐blind, placebo controlled trial. Annals of Internal Medicine1994;121(11):833‐41. ">Morgan 1994</a>; <a href="./references#CD000951-bbs2-0004" title="ShirokyJ , NevilleC , EsdaileJ , et al. Low dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a randomized, double‐blind, placebo controlled trial. Arthritis and Rheumatism1993;36(3):795‐803. ">Shiroky 1993</a>; <a href="./references#CD000951-bbs2-0005" title="VanEdeA , LaanR , BlomH , HuizingaT , HaagsmaC , GiesendorfB , et al. The C677T mutation in the methylenetetrahydrofolate reductase gene. A genetic risk factor for methotrexate‐related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis and Rheumatism2001;44(11):2525‐30. ">Van Ede 2001</a>; <a href="./references#CD000951-bbs2-0006" title="WeinblattM , MaierA , CoblynJ . Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 weeks randomized placebo controlled trial. Journal of Rheumatology1993;20:950‐2. ">Weinblatt 1993</a>). Four studies adequately blinded assessors to type of intervention (low risk of bias) (<a href="./references#CD000951-bbs2-0001" title="BuckleyL , VacekP , CooperS . Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. Journal of Rheumatology1990;17:1158‐61. ">Buckley 1990</a>; <a href="./references#CD000951-bbs2-0002" title="MorganSL , BaggottJ , VaughnW , YoungP , AustinJ , KrumdieckC , AlarconS . The effect of folic acid supplementation on the toxicity of low‐dose methotrexate in patients with rheumatoid arthritis. Arthritis and Rheumatism1990;33(1):9‐18. ">Morgan 1990</a>; <a href="./references#CD000951-bbs2-0003" title="MorganS , BaggotJ , VaughnW , et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double‐blind, placebo controlled trial. Annals of Internal Medicine1994;121(11):833‐41. ">Morgan 1994</a>; <a href="./references#CD000951-bbs2-0004" title="ShirokyJ , NevilleC , EsdaileJ , et al. Low dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a randomized, double‐blind, placebo controlled trial. Arthritis and Rheumatism1993;36(3):795‐803. ">Shiroky 1993</a>). </p> </section> <section id="CD000951-sec-0087"> <h4 class="title">Incomplete outcome data</h4> <p>Only one study was judged as appropriately addressing incomplete outcome data (low risk of bias) (<a href="./references#CD000951-bbs2-0006" title="WeinblattM , MaierA , CoblynJ . Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 weeks randomized placebo controlled trial. Journal of Rheumatology1993;20:950‐2. ">Weinblatt 1993</a>). </p> </section> <section id="CD000951-sec-0088"> <h4 class="title">Selective reporting</h4> <p>Only one was judged as appropriately addressing incomplete outcome data (low risk of bias) (<a href="./references#CD000951-bbs2-0005" title="VanEdeA , LaanR , BlomH , HuizingaT , HaagsmaC , GiesendorfB , et al. The C677T mutation in the methylenetetrahydrofolate reductase gene. A genetic risk factor for methotrexate‐related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis and Rheumatism2001;44(11):2525‐30. ">Van Ede 2001</a>). </p> </section> <section id="CD000951-sec-0089"> <h4 class="title">Other potential sources of bias</h4> <p>Treatment and control groups were comparable at entry in three studies (low risk of bias) (<a href="./references#CD000951-bbs2-0003" title="MorganS , BaggotJ , VaughnW , et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double‐blind, placebo controlled trial. Annals of Internal Medicine1994;121(11):833‐41. ">Morgan 1994</a>; <a href="./references#CD000951-bbs2-0004" title="ShirokyJ , NevilleC , EsdaileJ , et al. Low dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a randomized, double‐blind, placebo controlled trial. Arthritis and Rheumatism1993;36(3):795‐803. ">Shiroky 1993</a>; <a href="./references#CD000951-bbs2-0005" title="VanEdeA , LaanR , BlomH , HuizingaT , HaagsmaC , GiesendorfB , et al. The C677T mutation in the methylenetetrahydrofolate reductase gene. A genetic risk factor for methotrexate‐related elevation of liver enzymes in rheumatoid arthritis patients. Arthritis and Rheumatism2001;44(11):2525‐30. ">Van Ede 2001</a>) and significant differences were present in three studies indicating a high risk of bias (<a href="./references#CD000951-bbs2-0001" title="BuckleyL , VacekP , CooperS . Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis. Journal of Rheumatology1990;17:1158‐61. ">Buckley 1990</a>; <a href="./references#CD000951-bbs2-0002" title="MorganSL , BaggottJ , VaughnW , YoungP , AustinJ , KrumdieckC , AlarconS . The effect of folic acid supplementation on the toxicity of low‐dose methotrexate in patients with rheumatoid arthritis. Arthritis and Rheumatism1990;33(1):9‐18. ">Morgan 1990</a>; <a href="./references#CD000951-bbs2-0006" title="WeinblattM , MaierA , CoblynJ . Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 weeks randomized placebo controlled trial. Journal of Rheumatology1993;20:950‐2. ">Weinblatt 1993</a>). </p> </section> </section> <section id="CD000951-sec-0090"> <h3 class="title" id="CD000951-sec-0090">Effects of interventions</h3> <p>See: <a href="./full#CD000951-tbl-0001"><b>Summary of findings for the main comparison</b> Folic or folinic acid (any) compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</a>; <a href="./full#CD000951-tbl-0002"><b>Summary of findings 2</b> Folic acid compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</a>; <a href="./full#CD000951-tbl-0003"><b>Summary of findings 3</b> Folinic acid compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</a> </p> <p>Six trials with 624 participants met the inclusion criteria. There was no heterogeneity between included trials. </p> <section id="CD000951-sec-0091"> <h4 class="title">Folic acid versus placebo</h4> <p>An 81% relative (16.8% absolute) reduction in risk was observed for the incidence of abnormal serum transaminase levels (RR 0.19, 95% CI 0.10 to 0.36; P ≤ 0.00001), and there was a statistically significant decrease in the number of people who dropped out of the studies for any reason whilst taking folic acid (‐14.2% absolute difference; RR 0.43, 95% CI 0.29 to 0.64; P ≤ 0.0001). </p> <p>A 24% relative (8.1% absolute) reduction was seen for the risk of developing gastrointestinal (GI) side effects such as nausea, vomiting or abdominal pain although this failed to reach statistical significance (RR 0.76, 95% CI 0.57 to 1.01; P = 0.057). A trend towards a reduction in the incidence of stomatitis (mouth sores) was seen however this also failed to reach statistical significance (RR 0.90, 95% CI 0.53 to 1.54; P = 0.71). </p> </section> <section id="CD000951-sec-0092"> <h4 class="title">Folinic acid versus placebo</h4> <p>A 73% relative (15.2% absolute) reduction in risk was observed for the incidence of abnormal serum transaminase levels (RR 0.27, 95% CI 0.16 to 0.44; P ≤ 0.00001), and there was a statistically significant decrease in the number of people who dropped out of the studies for any reason whilst taking folinic acid (‐16.2% absolute difference; RR 0.35, 95% CI 0.23 to 0.53; P ≤ 0.00001). </p> <p>A 22% relative (7.6% absolute) reduction was seen for the risk of developing GI side effects such as nausea, vomiting or abdominal pain however this failed to reach statistical significance (RR 0.78, 95% CI 0.59 to 1.02; P = 0.066). Similarly, a trend towards a reduction in the incidence of stomatitis (mouth sores) was seen. This too failed to reach statistical significance (RR 0.70, 95% CI 0.46 to 1.07; P = 0.10). </p> <p>It was not possible to draw meaningful conclusions on the effect of folic or folinic acid on haematologic side effects of MTX due to the small numbers of events and poor reporting of this outcome in included trials, as described above. </p> </section> <section id="CD000951-sec-0093"> <h4 class="title">Effect of folic or folinic acid on disease activity (efficacy of methotrexate)</h4> <p>No statistically significant difference in disease activity (ie, no statistically significant lowering of the effectiveness of the methotrexate to treat rheumatoid arthritis) was observed between placebo and folic or folinic acid at low dosages. There was a slight trend towards an increased number of tender joints in patients treated with folic acid (+2.46 swollen joints per patient [95% CI ‐6.08 to 11.00; P 0.61]), and both tender and swollen joints for folinic acid (+1.13 tender joints per patient [95% CI ‐4.25 to 6.51; P 0.68], and +1.72 swollen joints per patient [95% CI ‐3.47 to 6.92; P 0.52]), however the wide confidence intervals suggest this is likely due to chance. </p> <p>The mean differences (MD) in disease activity (swollen and tender joint count, patient global assessment) between placebo or folate supplementation were analysed. There was no evidence of a reduction in the  MDs in disease activity (swollen and tender joint count, patient global assessment) in the  folate supplementation groups compared to placebo. </p> </section> <section id="CD000951-sec-0094"> <h4 class="title">Folic acid or folinic acid versus placebo</h4> <p>When studies using either folic acid or folinic acid were pooled together, the results were similar to the analyses of the individual agents versus placebo. </p> <p>A funnel plot to assess publication bias was not provided as there were not enough included studies to conduct this type of analysis. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD000951-sec-0095" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD000951-sec-0095"></div> <section id="CD000951-sec-0096"> <h3 class="title" id="CD000951-sec-0096">Summary of main results</h3> <p>The results support the protective effect of folic or folinic supplementation in patients with rheumatoid arthritis during treatment with MTX. There was a statistically significant reduction in the incidence of abnormal transaminase elevation as well as a statistically significant reduction in discontinuation of MTX treatment for any reason in the population studied. A trend towards a reduction in gastrointestinal side effects and stomatitis was demonstrated and although this did not reach statistical significance the concurrent statistically significant reduction in discontinuation of MTX treatment for any reason may indicate that the decrease in these side effects was greatest where the side effects were severe enough to result in MTX withdrawal. </p> <p>Although the analysis of haematologic side effects was made difficult by small numbers of events and the outcome being poorly reported in included studies, pooled trials reported no statistically significant differences between rheumatoid arthritis patients who received folate supplementation or placebo. The incidence of clinically important cytopenia in patients treated with low dose MTX is estimated to be less than 1% (<a href="http://Canadian Pharmaceuticals Association 1996" target="_blank">Canadian Pharmaceuticals Association 1996</a>), and therefore the size of a trial designed to detect any differences would be enormous. </p> </section> <section id="CD000951-sec-0097"> <h3 class="title" id="CD000951-sec-0097">Overall completeness and applicability of evidence</h3> <p>Sample size could potentially be a confounding variable since only one folinic acid study entered more than 40 patients per group. Interestingly, it appears that the benefit shown was greater for trials with higher numbers of patients and overall higher quality. Several authors (<a href="./references#CD000951-bbs2-0022" title="DijkmansB . Folate supplementation and methotrexate. British Journal of Rheumatology1995;34:1172‐4. ">Dijkmans 1995</a>; <a href="./references#CD000951-bbs2-0027" title="FurstD , ClementsP . Pharmacological approaches. SAARDs‐ II. Rheumatology1994;13:1‐8. ">Furst 1994</a>) have reported that the inverse is usually true with lower quality studies showing greater benefits, suggesting biases from poor design. The finding of a trend in the opposite direction in this meta‐analysis is reassuring and indicates the likely validity of the reduction of side effects from folate co‐administration. </p> <p>A concern with meta‐analysis is the potential existence of publication bias. It is possible that some trials have been completed that found no benefit of folic or folinic acid supplementation. It is difficult to be more definitive about publication bias in this review but we feel it is unlikely that we would be unaware of negative studies of sufficient size to eliminate the benefit seen in this meta‐analysis. </p> <p>Three studies (excluded from our analysis) have suggested that high dose folinic acid supplementation may reduce the beneficial effects of MTX on rheumatoid arthritis (<a href="./references#CD000951-bbs2-0009" title="GriffithS , FisherJ , ClarkeS , MontgomeryB , JonesP , SaklatvalaJ , et al. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?. Rheumatology2000;39:1102‐9. ">Griffith 2000</a>; <a href="./references#CD000951-bbs2-0011" title="JoyceD , WillD , HoffmanD , LaingB , BlackbournS . Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Annals of the Rheumatic Diseases1991;50:913‐4. ">Joyce 1991</a>; <a href="./references#CD000951-bbs2-0014" title="TishlerM , CaspiD , FishelB , YaronM . The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients. Arthritis and Rheumatism1988;31(7):906‐8. ">Tishler 1988</a>). In a previous version of this review (where these trials were included) there was a difference observed for high dose folinic acid which may have suggested a decrease in benefit of the MTX on the arthritis (an isolated increase in the number of tender joints but not in other clinical variables such as patient global assessment). These results were mostly driven by the study by Joyce et al and in our view are still non‐conclusive. We analysed the effect of adding these studies back into our meta‐analysis, and even when these studies were added back the overall results did not show a statistically significant decrease in MTX efficacy. </p> <p>There are no studies that suggest folic acid may alter the efficacy of MTX, despite a folic acid to MTX ratio in some trials higher than the folinic acid to MTX ratio used in the study by <a href="./references#CD000951-bbs2-0011" title="JoyceD , WillD , HoffmanD , LaingB , BlackbournS . Exacerbation of rheumatoid arthritis in patients treated with methotrexate after administration of folinic acid. Annals of the Rheumatic Diseases1991;50:913‐4. ">Joyce 1991</a> which suggested a decrease in MTX efficacy. We did not find any major differences in disease activity between placebo and folic acid at low dosages. </p> <p>It is possible that the timing of administration of folinic acid and MTX, as well as the folinic acid to MTX ratio, may alter the efficacy of MTX and it should be noted that this question was not possible to include in the design of this review. </p> <p>Our results support the protective effects of low dose folate supplementation in reducing GI and hepatic side effects of MTX in patients with rheumatoid arthritis. This is consistent with the recommendations by some authors (<a href="./references#CD000951-bbs2-0023" title="DrummondM , Bosi FerrazM , MasonJ . Assessing the cost effectiveness of NSAID: an international perspective. Journal of Rheumatology1995;22(7):1408‐14. ">Drummond 1995</a>; <a href="./references#CD000951-bbs2-0041" title="MorganS , AlarcónG , KrumdieckC . Folic acid supplementation during methotrexate therapy: it makes sense [Editorial]. Journal of Rheumatology1993;20(6):929‐30. ">Morgan 1993</a>; <a href="./references#CD000951-bbs2-0004" title="ShirokyJ , NevilleC , EsdaileJ , et al. Low dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a randomized, double‐blind, placebo controlled trial. Arthritis and Rheumatism1993;36(3):795‐803. ">Shiroky 1993</a>; <a href="./references#CD000951-bbs2-0006" title="WeinblattM , MaierA , CoblynJ . Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 weeks randomized placebo controlled trial. Journal of Rheumatology1993;20:950‐2. ">Weinblatt 1993</a>), as well as current prescribing guidelines. </p> <p>Deciding which of the two forms of folate supplementation should be recommended is more difficult. Experts have differing recommendations, often acknowledging that there is insufficient evidence for advising the use of one compound over the other (<a href="http://Borigini 1995" target="_blank">Borigini 1995</a>; <a href="./references#CD000951-bbs2-0022" title="DijkmansB . Folate supplementation and methotrexate. British Journal of Rheumatology1995;34:1172‐4. ">Dijkmans 1995</a>; <a href="./references#CD000951-bbs2-0027" title="FurstD , ClementsP . Pharmacological approaches. SAARDs‐ II. Rheumatology1994;13:1‐8. ">Furst 1994</a>; <a href="./references#CD000951-bbs2-0044" title="SalachR , CashJ . Methotrexate: The emerging drug of choice for serious rheumatoid arthritis. Clinical Therapeutics1994;16(6):912‐22. ">Salach 1994</a>; <a href="./references#CD000951-bbs2-0045" title="SchnabelA , GrossWl . Low‐dose methotrexate in rheumatic diseases: efficacy, side effects and risk factors for side effects. Seminars in Arthritis and Rheumatism1994;23:310‐27. ">Schnabel 1994</a>; <a href="./references#CD000951-bbs2-0006" title="WeinblattM , MaierA , CoblynJ . Low dose leucovorin does not interfere with the efficacy of methotrexate in rheumatoid arthritis: an 8 weeks randomized placebo controlled trial. Journal of Rheumatology1993;20:950‐2. ">Weinblatt 1993</a>). There is no evidence to date of a significant difference between folic or folinic acid. The results in this meta‐analysis were less impressive for folinic acid, but four of the five studies had small sample sizes and the larger study by Shiroky et al did show a benefit. </p> <p>Given both the efficacy of folic acid in reducing MTX side effects and its low cost compared to folinic acid, the use of folic acid is likely to be the more cost‐effective therapy. For folinic acid to be considered cost‐effective it must be proven more effective than folic acid at reducing MTX side effects. One study (<a href="./references#CD000951-bbs2-0029" title="HartmanM , VanEdeAE , SeverensJL , LaanR , van dePutteL , van derWiltG . Economic evaluation of folate supplementation during methotrexate treatment in rheumatoid arthritis. Journal Of Rheumatology2004;31(5):902‐8. ">Hartman 2004</a>) examined the economics of folate supplementation in rheumatoid arthritis patients in detail and concluded that, aside from the differences in cost between folic and folinic acid, potentially the largest impact on overall treatment costs relates to the increased drug survival seen with either agent. If folate supplements can help patients tolerate MTX for longer, it may delay or prevent a change in treatment to a far more expensive biologic agent. </p> <p>It is unclear whether all patients on MTX, or only those with side effects, should receive folate supplementation. This systematic review cannot address this issue. Most guidelines and texts recommend folate be given to all patients receiving methotrexate. Yet the effects of folic or folinic acid on the development of liver disease are unknown. It has been suggested that supplementation may have a protective effect on the development of liver disease, in which case universal administration could perhaps be considered. </p> <p>In summary, supplementation with folic or folinic acid in MTX treated rheumatoid arthritis patients provides a reduction in the incidence of abnormal liver function tests and a reduction in overall withdrawal from treatment. There is also a trend towards a reduction in the incidence of gastrointestinal side effects and stomatitis. The results of our review do not suggest any clear clinical advantage of one form of folate over the other. </p> </section> <section id="CD000951-sec-0098"> <h3 class="title" id="CD000951-sec-0098">Quality of the evidence</h3> <p>A major problem in synthesising evidence is the lack of uniformity in outcome measures. In 1994, during the Conference on Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT), it was determined that a core set of toxicity measures needed to be established for antirheumatic drugs. This set will allow researchers to compare data across all trials with accurate meta‐analyses of toxicity (<a href="./references#CD000951-bbs2-0018" title="BrooksP , DayR . Toxicity of antirheumatic drugs. Journal of Rheumatology1995;22(5):998‐90. ">Brooks 1995</a>). Published guidelines also urge investigators to provide simple tabulation of the incidence of adverse events per patient even where indices are used to allow the reader to understand how the index was computed and the extent to which more patients had single or multiple adverse experiences. We also encourage investigators to describe fully the numbers and flow of patients by treatment group throughout the trial and to clearly report the reasons for dropouts for each group. This meta‐analysis was hampered by lack of uniformity in the way these items were reported. </p> </section> <section id="CD000951-sec-0099"> <h3 class="title" id="CD000951-sec-0099">Potential biases in the review process</h3> <p>The review was restricted to RCTs; we excluded clinical controlled trials (CCTs) thus limiting the potential for bias. All studies described themselves as randomised mostly without giving details of how the randomisation sequence was generated and what precautions were taken in relation to concealment of allocation. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD000951-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD000951-fig-0001" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study." data-id="CD000951-fig-0002" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies." data-id="CD000951-fig-0003" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Folic acid versus placebo, Outcome 1 Nausea / GI upset." data-id="CD000951-fig-0004" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Folic acid versus placebo, Outcome 1 Nausea / GI upset.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Folic acid versus placebo, Outcome 2 Stomatitis." data-id="CD000951-fig-0005" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Folic acid versus placebo, Outcome 2 Stomatitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Folic acid versus placebo, Outcome 3 Liver toxicity." data-id="CD000951-fig-0006" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Folic acid versus placebo, Outcome 3 Liver toxicity.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Folic acid versus placebo, Outcome 4 Neutropenia." data-id="CD000951-fig-0007" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Folic acid versus placebo, Outcome 4 Neutropenia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Folic acid versus placebo, Outcome 5 Total withdrawals." data-id="CD000951-fig-0008" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Folic acid versus placebo, Outcome 5 Total withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Folic acid versus placebo, Outcome 6 Tender Joints." data-id="CD000951-fig-0009" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Folic acid versus placebo, Outcome 6 Tender Joints.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Folic acid versus placebo, Outcome 7 Swollen Joints." data-id="CD000951-fig-0010" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Folic acid versus placebo, Outcome 7 Swollen Joints.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Folic acid versus placebo, Outcome 8 Patient global assessment." data-id="CD000951-fig-0011" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Folic acid versus placebo, Outcome 8 Patient global assessment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Folinic acid versus placebo, Outcome 1 Nausea / GI upset." data-id="CD000951-fig-0012" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Folinic acid versus placebo, Outcome 1 Nausea / GI upset.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Folinic acid versus placebo, Outcome 2 Stomatitis." data-id="CD000951-fig-0013" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Folinic acid versus placebo, Outcome 2 Stomatitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Folinic acid versus placebo, Outcome 3 Liver toxicity." data-id="CD000951-fig-0014" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Folinic acid versus placebo, Outcome 3 Liver toxicity.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Folinic acid versus placebo, Outcome 4 Neutropenia." data-id="CD000951-fig-0015" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Folinic acid versus placebo, Outcome 4 Neutropenia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Folinic acid versus placebo, Outcome 5 Total withdrawals." data-id="CD000951-fig-0016" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Folinic acid versus placebo, Outcome 5 Total withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Folinic acid versus placebo, Outcome 6 Tender Joints." data-id="CD000951-fig-0017" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Folinic acid versus placebo, Outcome 6 Tender Joints.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Folinic acid versus placebo, Outcome 7 Swollen Joints." data-id="CD000951-fig-0018" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Folinic acid versus placebo, Outcome 7 Swollen Joints.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Folinic acid versus placebo, Outcome 8 Patient global assessment." data-id="CD000951-fig-0019" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Folinic acid versus placebo, Outcome 8 Patient global assessment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Folic or folinic acid versus placebo, Outcome 1 Nausea / GI upset." data-id="CD000951-fig-0020" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Folic or folinic acid versus placebo, Outcome 1 Nausea / GI upset.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Folic or folinic acid versus placebo, Outcome 2 Stomatitis." data-id="CD000951-fig-0021" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Folic or folinic acid versus placebo, Outcome 2 Stomatitis.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Folic or folinic acid versus placebo, Outcome 3 Liver toxicity." data-id="CD000951-fig-0022" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Folic or folinic acid versus placebo, Outcome 3 Liver toxicity.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Folic or folinic acid versus placebo, Outcome 4 Neutropenia." data-id="CD000951-fig-0023" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Folic or folinic acid versus placebo, Outcome 4 Neutropenia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Folic or folinic acid versus placebo, Outcome 5 Total withdrawals." data-id="CD000951-fig-0024" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Folic or folinic acid versus placebo, Outcome 5 Total withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Folic or folinic acid versus placebo, Outcome 6 Tender Joints." data-id="CD000951-fig-0025" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Folic or folinic acid versus placebo, Outcome 6 Tender Joints.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Folic or folinic acid versus placebo, Outcome 7 Swollen Joints." data-id="CD000951-fig-0026" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Folic or folinic acid versus placebo, Outcome 7 Swollen Joints.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Folic or folinic acid versus placebo, Outcome 8 Patient Global Assessment." data-id="CD000951-fig-0027" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Folic or folinic acid versus placebo, Outcome 8 Patient Global Assessment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Folic acid versus folinic acid, Outcome 1 GI side effects." data-id="CD000951-fig-0028" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Folic acid versus folinic acid, Outcome 1 GI side effects.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Folic acid versus folinic acid, Outcome 2 Liver toxicity." data-id="CD000951-fig-0029" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Folic acid versus folinic acid, Outcome 2 Liver toxicity.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD000951-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/urn:x-wiley:14651858:media:CD000951:CD000951-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_t/tCD000951-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Folic acid versus folinic acid, Outcome 3 Total withdrawals." data-id="CD000951-fig-0030" src="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Folic acid versus folinic acid, Outcome 3 Total withdrawals.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/media/CDSR/CD000951/image_n/nCD000951-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD000951-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Folic or folinic acid (any) compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Folic acid or folinic acid (any) compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients receiving methotrexate for rheumatoid arthritis<br/> <b>Settings:</b> International hospital and clinic settings<br/> <b>Intervention:</b> Supplementation with either folic or folinic acid<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Supplementation with either folic or folinic acid</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>GI side effects (nausea, vomiting, abdominal pain)</b> </p> <p>Follow‐up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>346 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>256 per 1000</b> <br/> (204 to 318) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.74</b> (0.59 to 0.92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>644<br/> (6 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction: ‐9.0% (‐14.2% to ‐2.8%) (P = 0.008)</p> <p>Relative risk reduction: ‐26.0% (‐41.0% to ‐8.1%)</p> <p>NNT: 11 (7 to 35)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stomatitis / mouth sores (incidence)</b> </p> <p>Follow‐up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>223 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>161 per 1000</b> <br/> (109 to 236) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.72</b> (0.49 to 1.06) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>575<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk difference: ‐6.2% (‐11.4% to +1.3%)</p> <p>Relative risk difference: ‐27.8% (‐51.1% to +5.8%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Liver toxicity (incidence of transaminase elevation)</b> </p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>208 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>48 per 1000</b> <br/> (31 to 71) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.23</b> (0.15 to 0.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>551<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction: ‐16.0% (‐17.7% to ‐13.7%) (P &lt;0.00001)</p> <p>Relative risk reduction: ‐76.9% (‐85.1% to ‐65.9%)</p> <p>NNT: 6 (6 to 7)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Haematological disorders</b> (neutropenia, etc) </p> <p>Follow up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>&lt;10 per 1000</b><sup>2</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.55</b> (0.40 to 5.91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>443<br/> (2 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This is a rare event<sup>2</sup>. The studies included in this review were underpowered to detect a meaningful difference in rates of neutropenia. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total withdrawals</b> </p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>98 per 1000</b> <br/> (70 to 133) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.39</b> (0.28 to 0.53) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>640<br/> (6 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction: ‐15.2% (‐18.0% to ‐11.7%) (P &lt;0.00001)</p> <p>Relative risk reduction: ‐60.8% (‐72.0% to ‐46.8%)</p> <p>NNT: 7 (6 to 9)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of swollen joints</b> </p> <p>Change in number of swollen joints</p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of swollen joints per patient in the control group is <b>18.24</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of swollen joints per patient = <b>18.47</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>142 patients (4 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardized Mean Difference (SMD)</p> <p>between groups in number of swollen joints = 0.05 (‐0.28 to 0.38)</p> <p>Absolute risk difference: 4.82% (‐27.01% to 36.6%)</p> <p>Relative risk difference: 26.42% (‐148.08% to 201.04%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of tender joints</b> </p> <p>Change in number of tender joints</p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of tender joints per patient in the control group is <b>15.23</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of tender joints per patient = <b>16.05</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>122 patients</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardized Mean Difference (SMD)</p> <p>between groups in number of tender joints = 0.09 (‐0.27 to 0.45)</p> <p>Absolute risk difference: 4.55% (‐13.65% to 22.75%)</p> <p>Relative risk difference: 29.88% (‐89.63% to 149.38%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; NNT; number needed to treat </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Number of events is less than 300. </p> <p><sup>2</sup>The incidence of clinically important cytopenia in patients treated with low‐dose MTX is estimated to be less than 1%. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Folic or folinic acid (any) compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000951-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Folic acid compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Folic acid compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients receiving methotrexate for rheumatoid arthritis<br/> <b>Settings:</b> International hospital and clinic settings<br/> <b>Intervention:</b> Supplementation with folic acid<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Folic Acid</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>GI side effects (ie, incidence of nausea, vomiting, abdominal pain)</b> <br/> <br/> Follow‐up: 24 to 52 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>346 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>263 per 1000</b> <br/> (197 to 349) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.76</b> (0.57 to 1.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>355<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk difference = ‐8.3% (‐14.9% to 0.3%)</p> <p>Relative risk difference = ‐24.0% (‐43.1% to 0.8%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Stomatitis / mouth sores (incidence)</b> </p> <p>Follow‐up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>223 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>201 per 1000</b> </p> <p>(118 to 343)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.90</b> (0.53 to 1.54) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>302</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Absolute risk difference = ‐2.2% (‐10.5% to 12.0%)</p> <p>Relative risk difference = ‐9.9% (‐47.1% to 53.8%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Liver toxicity (ie, incidence of transaminase elevation)</b> </p> <p>Follow‐up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>208 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b> <br/> (21 to 75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.19</b> (0.10 to 0.36) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>302<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction = ‐16.8% (‐18.7% to ‐13.3%)</p> <p>(P &lt; 0.00001)</p> <p>Relative risk reduction = ‐80.8% (‐89.9% to ‐63.9%)</p> <p>NNT = 6 (5 to 8)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Haematological disorders</b> (incidence of neutropenia, etc) </p> <p>Follow up: 24 to 48 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>&lt;10 per 1000</b><sup>3</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.70</b> </p> <p>(0.42 to 6.96)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>443</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This is a rare event<sup>3</sup>. The studies included in this review were underpowered to detect a meaningful difference in rates of neutropenia. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total withdrawals</b> </p> <p>Follow‐up: 24 to 48 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000*</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>108 per 1000</b> <br/> (73 to 160) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.43</b> <br/> (0.29 to 0.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>343<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction = ‐14.2% (‐17.7% to ‐9.0%)</p> <p>(P=0.000039)</p> <p>Relative risk difference = ‐56.8% (‐70.8% to ‐36.0%)</p> <p>NNT = 7 (6 to 11)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of swollen joints with folic acid (</b> ≤<b>7 mg/wk)</b> <br/> Change in number of swollen joints </p> <p>Follow‐up: 48 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of swollen joints per patient = <b>16.00</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of swollen joints per patient = <b>14.35</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference between groups in number of swollen joints (Absolute difference)= ‐1.65 (‐7.96 to 4.66)<sup>4</sup> </p> <p>Relative risk difference: ‐10.4% (‐49.8% to 29.1%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of tender joints with folic acid (</b> ≤<b>7 mg/wk)</b> <br/> Change in number of tender joints </p> <p>Follow‐up: 48 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of tender joints per patient = <b>17.63</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of tender joints per patient = <b>20.09</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42<br/> (1 study) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference between groups in number of tender joints = 2.46 (‐6.08 to 11.00)<sup>5</sup> </p> <p>Absolute risk difference:</p> <p>Relative risk difference: 14.0% (‐34.5% to 62.4%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; R<b>R:</b> Risk ratio; <b>NNT</b>: Number needed to treat </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Number of events is less than 300 </p> <p><sup>2</sup> Less than 400 participants </p> <p><sup>3</sup>The incidence of clinically important cytopenia in patients treated with low dose MTX is estimated to be less than 1%. </p> <p><sup>4</sup> Post‐treatment number of swollen joints not reported. Change scores presented here. </p> <p><sup>5</sup> Post‐treatment number of tender joints not reported. Change scores presented here. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Folic acid compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD000951-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Folinic acid compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Folinic acid compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Patients receiving methotrexate for rheumatoid arthritis<br/> <b>Settings:</b> International hospital and clinic settings<br/> <b>Intervention:</b> Supplemtation with folinic acid<br/> <b>Comparison:</b> Placebo </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Folinic Acid</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>GI side effects (nausea, vomiting, abdominal pain)</b> </p> <p>Follow‐up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>346 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>270 per 1000</b> <br/> (204 to 353) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.78</b> (0.59 to 1.02) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>426<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk difference: ‐7.6% (‐14.2% to 0.7%)</p> <p>Relative risk difference: ‐22.0% (‐41.0 to 2.0%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Stomatitis / mouth sores (incidence)</b> </p> <p>Follow‐up: 24 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>223 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>156 per 1000</b> </p> <p>(103 to 239)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.70</b> (0.46 to 1.07) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>410 (3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Absolute risk difference: ‐6.7% (‐12.0% to 0.16%)</p> <p>Relative risk difference: ‐30.0% (‐53.8% to 7.2%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Liver toxicity (incidence of transaminase elevation)</b> </p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>208 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>56 per 1000</b> <br/> (33 to 92) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.27</b> (0.16 to 0.44) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>358<br/> (3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction: ‐15.2% (‐17.5% to ‐11.6%)</p> <p>Relative risk reduction: ‐73.1% (‐84.1% to ‐55.8%)</p> <p>NNT: 7 (6 to 9)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Haematological disorders</b> (neutropenia, etc) </p> <p>Follow‐up: 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>&lt;10 per 1000</b><sup>3</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 1.46</b> (0.25 to 8.59) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>278</p> <p>(1 study)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>This is a rare event<sup>3</sup>. The studies included in this review were underpowered to detect a meaningful difference in rates of neutropenia. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Total withdrawals</b> </p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>250 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>88 per 1000</b> <br/> (58 to 133) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.35</b> (0.23 to 0.53) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>386<br/> (3 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Absolute risk reduction: ‐16.2% (‐19.2% to ‐11.7%)</p> <p>Relative risk reduction: ‐64.8% (‐76.8% to ‐46.8%)</p> <p>NNT: 6 (5 to 9)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of swollen joints with folinic acid (</b> ≤<b>7 mg/wk)</b> <br/> Change in number of swollen joints </p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of swollen joints per patient = <b>19.13</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of swollen joints per patient = <b>20.29</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> <p>(3 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference between groups in number of swollen joints (Absolute difference) = 1.72 (‐3.47 to 6.92)<sup>4</sup> </p> <p>Relative risk difference: 8.1% (‐16.3% to 32.6%)</p> <p>Not statisticaly significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of tender joints with folinic acid (</b> ≤<b>7 mg/wk)</b> <br/> Change in number of tender joints </p> <p>Follow‐up: 8 to 52 weeks</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of tender joints per patient = <b>14</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>Mean no. of tender joints per patient = <b>13.88</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> <p>(2 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean difference between groups in number of tender joints (Absolute difference) = 1.13 (‐4.25 to 6.51)<sup>5</sup> </p> <p>Relative risk difference: 6.3% (‐23.9% to 36.6%)</p> <p>Not statistically significant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; <b>NNT</b>; number needed to treat </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Number of events is less than 300.<br/> <sup>2</sup> Less than 400 participants. </p> <p><sup>3</sup>The incidence of clinically important cytopenia in patients treated with low‐dose MTX is estimated to be less than 1%.<br/> <sup>4</sup> Post‐treatment number of swollen joints not reported. Change scores presented here.<br/> <sup>5</sup> Post‐treatment number of tender joints not reported. Change scores presented here. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Folinic acid compared to placebo for reducing side effects in patients receiving methotrexate for rheumatoid arthritis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD000951-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Search summary</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Database(s)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Search Date</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Results (n=)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Notes</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MEDLINE (1966‐1999), CCTR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>January 1966‐June 1999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133 after duplicates removed</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MEDLINE, PubMed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1999 ‐ June 2011</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See footnote<sup>1</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MEDLINE, PubMed, EMBASE, CENTRAL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1999‐March 2012</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>192 after duplicates removed</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total after duplicates removed</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><sup>1</sup>In 2011 this review was assessed as suitable for a 'streamlined' update search procedure. A Boolean serach of intervention and condition terms was combined with a Randomised Controlled Trial filter from 1999 until June 2011. A Pubmed 'related items' search was also carried out of the 3 largest and 3 most recent included studies from the original review. </p> <p>During the 2012 review, the search was re‐run, and back‐dated to follow on from the original search (1999). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Search summary</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/full#CD000951-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000951-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Folic acid versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Nausea / GI upset <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>355</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.57, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Stomatitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.53, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Liver toxicity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [0.10, 0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Neutropenia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.42, 6.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Total withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>355</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.29, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Tender Joints <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [‐6.08, 11.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Swollen Joints <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.65 [‐7.96, 4.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Patient global assessment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.50, 0.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Folic acid versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000951-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Folinic acid versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Nausea / GI upset <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>426</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.59, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Stomatitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.46, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Liver toxicity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>386</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.16, 0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Neutropenia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.25, 8.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Total withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>422</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.23, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Tender Joints <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [‐4.25, 6.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Swollen Joints <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.72 [‐3.47, 6.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Patient global assessment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [‐0.25, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Folinic acid versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000951-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Folic or folinic acid versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Nausea / GI upset <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>644</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.59, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Stomatitis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>575</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.49, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Liver toxicity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>551</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.23 [0.15, 0.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Neutropenia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>443</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [0.40, 5.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Total withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.28, 0.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Tender Joints <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.27, 0.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Swollen Joints <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [‐0.28, 0.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Patient Global Assessment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.22, 0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Folic or folinic acid versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD000951-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Folic acid versus folinic acid</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 GI side effects <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.86 [0.56, 6.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Liver toxicity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.28, 2.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Total withdrawals <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.43 [0.80, 2.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Folic acid versus folinic acid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD000951.pub2/references#CD000951-tbl-0008">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD000951.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD000951-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD000951-note-0010">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD000951-note-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD000951-note-0009">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD000951-note-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD000951-note-0007">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD000951-note-0005">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD000951-note-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD000951-note-0004">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD000951-note-0003">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD000951-note-0001">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD000951-note-0011">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000951\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000951\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000951\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD000951\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD000951\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=eLIOL3Be&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000951.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD000951.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD000951.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD000951.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD000951.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714754609"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000951.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714754613"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD000951.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d7669baa7937d',t:'MTc0MDcxNDc1NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 